Inhibition of tumor vasculogenic mimicry and prolongation of host survival in highly aggressive gallbladder cancers by norcantharidin via blocking the ephrin type a receptor 2/focal adhesion kinase/paxillin signaling pathway.
Vasculogenic mimicry (VM) is a newly-defined tumor microcirculation pattern in highly aggressive malignant tumors. We recently reported tumor growth and VM formation of gallbladder cancers through the contribution of the ephrin type a receptor 2 (EphA2)/focal adhesion kinase (FAK)/Paxillin signaling...
Main Authors: | Hui Wang, Wei Sun, Wen-Zhong Zhang, Chun-Yan Ge, Jing-Tao Zhang, Zhong-Yan Liu, Yue-Zu Fan |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24811250/pdf/?tool=EBI |
Similar Items
-
A pilot histomorphology and hemodynamic of vasculogenic mimicry in gallbladder carcinomas <it>in vivo </it>and <it>in vitro</it>
by: Zhang Wen Z, et al.
Published: (2011-04-01) -
Vasculogenic mimicry in carcinogenesis and clinical applications
by: Qingxi Luo, et al.
Published: (2020-03-01) -
Vasculogenic mimicry persists during glioblastoma xenograft growth
by: Cong Li, et al.
Published: (2018-01-01) -
HMGA2 promotes vasculogenic mimicry and tumor aggressiveness by upregulating Twist1 in gastric carcinoma
by: Junying Sun, et al.
Published: (2017-05-01) -
An Overview of Vasculogenic Mimicry in Breast Cancer
by: Marco A. Andonegui-Elguera, et al.
Published: (2020-02-01)